Real-time enrollment status for this triple negative breast cancer clinical trial
Current Status
Recruiting
Checked: July 17, 2026 at 8:57 AM UTC
| NCT Number | NCT05115474 |
| Recruiting Status | Recruiting |
| Condition | Triple Negative Breast Cancer |
| Phase | PHASE2 |
| Target Enrollment | 170 participants |
| Active Locations | 2 sites in the US |
| Sponsor | H. Lee Moffitt Cancer Center and Research Institute |
| Last Updated on CT.gov | May 18, 2026 (May 18, 2026) |
As of July 17, 2026: Clinical trial NCT05115474 is currently recruiting participants. This phase2 study for triple negative breast cancer is actively seeking new participants at 2 locations across the United States. The study is sponsored by H. Lee Moffitt Cancer Center and Research Institute. This status information is automatically verified from the official ClinicalTrials.gov registry.
Yes, NCT05115474 is actively recruiting participants as of July 17, 2026. You can check eligibility and apply through HelloStudys.
This trial is recruiting at 2 locations in the United States. View all available locations on the full study page.
Check your eligibility and express interest by completing the application form on the study page. A research coordinator will follow up to discuss next steps.
The official ClinicalTrials.gov record for NCT05115474 was last updated May 18, 2026 (May 18, 2026). HelloStudys verifies this status automatically.